Anthony E Getschman

Title: Anthony E Getschman: Innovator in Biopharmaceuticals

Introduction

Anthony E Getschman is a notable inventor based in Wauwatosa, WI (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of polypeptides for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Anthony's latest patents include the "Engineered CCL20 locked dimer polypeptide." This invention provides a CCL20 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of psoriasis and psoriatic arthritis. Another patent under his name also addresses the same polypeptide, emphasizing its use in treating psoriasis, inflammatory disorders, and autoimmune diseases.

Career Highlights

Anthony E Getschman is affiliated with the Medical College of Wisconsin, Inc., where he continues to advance his research and innovations. His work has the potential to impact the treatment landscape for patients suffering from chronic inflammatory conditions.

Collaborations

Some of his notable coworkers include Yasutomo Imai and Francis Peterson. Their collaborative efforts contribute to the ongoing research and development in the field of biopharmaceuticals.

Conclusion

Anthony E Getschman stands out as an influential inventor in the biopharmaceutical sector, with a focus on innovative treatments for psoriasis and related disorders. His contributions are paving the way for advancements in medical therapies.